Sep. 2 at 12:39 PM
$ANRGF
Read Thru – Another expansion contract from a major play energy player expanding their biomethane developments. I’ve done a write on Bioenerys in the past but here is a short recap. I have attached a key slide from Bioenerys website ( 31 current agri plants (many are potential upgrade opportunities) and “50 new plants under construction”. Anaergia has potential to capture additional business on both fronts with this customer ( upgrade and newbuilds). I’ll continue to re-iterate the investment thesis on Anaergia – large scale customer wins with tier 1 clients ( no counter party risk ) with expansion opportunities that will provide confidence in sustained long term revenue growth.
Bioenerys is a company leader in the production of biomethane that is 100% controlled by Snam Group ( €17 billion mkt cap – Snam SpA on Borsa Italian exchange ).
Snam S.p.A. is a leading European energy infrastructure company, primarily engaged in natural gas transportation, storage, and regasification, with growing investments in bioenergy (biomethane) and other renewable energy solutions. Its financial performance in 2025 reflects strong growth, driven by its core gas infrastructure business and strategic investments in the energy transition, including biomethane.
Full Year 2024 (Context for 2025):
• Adjusted EBITDA: €2.75 billion, up 14% from 2023, reflecting strong gas infrastructure earnings and contributions from energy transition activities like biomethane.
2025–2029 Strategic Plan:
• Capital Expenditure (Capex): €12.5 billion, up from €11.5 billion in the 2023–2027 plan, with significant allocations for bioenergy (biomethane) and hydrogen infrastructure to support decarbonization.